519 related articles for article (PubMed ID: 19567679)
41. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
42. Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo.
Garcia Casado J; Janda J; Wei J; Chapatte L; Colombetti S; Alves P; Ritter G; Ayyoub M; Valmori D; Chen W; Lévy F
Eur J Immunol; 2008 Jul; 38(7):1867-76. PubMed ID: 18546142
[TBL] [Abstract][Full Text] [Related]
43. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
[TBL] [Abstract][Full Text] [Related]
44. The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.
Terme M; Mignot G; Ullrich E; Bonmort M; Minard-Colin V; Jacquet A; Schultze JL; Kroemer G; Leclerc C; Chaput N; Zitvogel L
Cancer Res; 2009 Aug; 69(16):6590-7. PubMed ID: 19679551
[TBL] [Abstract][Full Text] [Related]
45. Genetically targeted T cells eradicate established breast cancer in syngeneic mice.
Wang H; Wei H; Zhang R; Hou S; Li B; Qian W; Zhang D; Kou G; Dai J; Guo Y
Clin Cancer Res; 2009 Feb; 15(3):943-50. PubMed ID: 19188165
[TBL] [Abstract][Full Text] [Related]
46. Synthetic CD4+ T cell-targeted antigen-presenting cells elicit protective antitumor responses.
Caserta S; Alessi P; Guarnerio J; Basso V; Mondino A
Cancer Res; 2008 Apr; 68(8):3010-8. PubMed ID: 18413771
[TBL] [Abstract][Full Text] [Related]
47. Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen.
Peinert S; Prince HM; Guru PM; Kershaw MH; Smyth MJ; Trapani JA; Gambell P; Harrison S; Scott AM; Smyth FE; Darcy PK; Tainton K; Neeson P; Ritchie DS; Hönemann D
Gene Ther; 2010 May; 17(5):678-86. PubMed ID: 20200563
[TBL] [Abstract][Full Text] [Related]
48. Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.
Mortara L; Frangione V; Castellani P; De Lerma Barbaro A; Accolla RS
Int Immunol; 2009 Jun; 21(6):655-65. PubMed ID: 19395374
[TBL] [Abstract][Full Text] [Related]
49. CD4+ T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection.
Cohen PA; Peng L; Plautz GE; Kim JA; Weng DE; Shu S
Crit Rev Immunol; 2000; 20(1):17-56. PubMed ID: 10770269
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of established tumor growth in syngeneic mice by local inoculation of engineered mouse myeloma cells secreting a recombinant fusion protein RM4/TNF.
Xiang J; Qi Y; Chen Y
Cancer Gene Ther; 1997; 4(6):353-8. PubMed ID: 9408605
[TBL] [Abstract][Full Text] [Related]
51. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
Han WG; Schuurhuis DH; Fu N; Camps M; van Duivenvoorde LM; Louis-Plence P; Franken KL; Huizinga TW; Melief CJ; Toes RE; Ossendorp F
Eur J Immunol; 2009 Jul; 39(7):1765-73. PubMed ID: 19544486
[TBL] [Abstract][Full Text] [Related]
52. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.
Nishikawa H; Sato E; Briones G; Chen LM; Matsuo M; Nagata Y; Ritter G; Jäger E; Nomura H; Kondo S; Tawara I; Kato T; Shiku H; Old LJ; Galán JE; Gnjatic S
J Clin Invest; 2006 Jul; 116(7):1946-54. PubMed ID: 16794737
[TBL] [Abstract][Full Text] [Related]
53. Different lineages of P1A-expressing cancer cells use divergent modes of immune evasion for T-cell adoptive therapy.
Bai XF; Liu JQ; Joshi PS; Wang L; Yin L; Labanowska J; Heerema N; Zheng P; Liu Y
Cancer Res; 2006 Aug; 66(16):8241-9. PubMed ID: 16912204
[TBL] [Abstract][Full Text] [Related]
54. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
[TBL] [Abstract][Full Text] [Related]
55. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
56. Induction of anti-tumor immunity by lyophilized myeloma cells secreting GM-CSF.
Wu S; Yuan D; Liu JN; Tan XY
Oncol Rep; 2007 Jan; 17(1):129-33. PubMed ID: 17143489
[TBL] [Abstract][Full Text] [Related]
57. Booster immunization of antigen primed mice with anti-idiotypic T cells generates antigen-specific memory T cell response.
Lal G; Shaila MS; Nayak R
Vaccine; 2006 Feb; 24(8):1149-58. PubMed ID: 16239053
[TBL] [Abstract][Full Text] [Related]
58. Large-scale production and characterization of novel CD4+ cytotoxic T cells with broad tumor specificity for immunotherapy.
Jursik C; Prchal M; Grillari-Voglauer R; Drbal K; Fuertbauer E; Jungfer H; Albert WH; Steinhuber E; Hemetsberger T; Grillari J; Stockinger H; Katinger H
Mol Cancer Res; 2009 Mar; 7(3):339-53. PubMed ID: 19240181
[TBL] [Abstract][Full Text] [Related]
59. Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity.
Hu J; Li G; Tong Y; Li Y; Zhou G; He X; Xie P; Wang JM; Sun Q
Int Immunopharmacol; 2005 Jun; 5(6):971-80. PubMed ID: 15829413
[TBL] [Abstract][Full Text] [Related]
60. Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cells.
Wall EM; Milne K; Martin ML; Watson PH; Theiss P; Nelson BH
Cancer Res; 2007 Jul; 67(13):6442-50. PubMed ID: 17616705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
